Okay. Thank you.
I was going to ask another question, and I will have to expand on it, because again my friend Mr. Davies asked it before I could. This is in regard to the secondary costs of non-compliance. We've discussed that at length. People who can't afford their medications become ill and present to the hospital system. Depending on the nature of their illness, that cost can be quite substantial. For diabetics who go into renal failure, dialysis is going to cost about $70,000 a year per patient.
The Morgan paper “Pharmacare 2020”, by Steve Morgan, says that with the system we have now, without the checks and balances of a national plan, we have “underuse, overuse, and misuse”. The best estimate is that it costs about $5 billion a year. Could we safely assume that if we had this in place and it prevented that, we might encounter savings that would be additional to the savings that you're suggesting?